use of non peptide antagonists of receptors for the prokineticine for therapy of autoimmune diseases or autoimmune component, or diseases disimmuni or disimmune component

摘要

The invention relates to a compound comprising non-peptide prokineticin receptors antagonists and agents that modulate or inhibit the activity of prokineticin receptors for use in the treatment of immune-mediated diseases of the central nervous system, peripheral nervous system and neuromuscular junctions.